CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA. [electronic resource]
Producer: 20190718Description: 39 p. digitalISSN:- 1129-2377
- Adolescent
- Adult
- Aged
- Botulinum Toxins, Type A -- therapeutic use
- Calcitonin Gene-Related Peptide -- genetics
- Chronic Disease
- Female
- Gene Frequency
- Genome-Wide Association Study -- methods
- Humans
- Middle Aged
- Migraine Disorders -- drug therapy
- Neuromuscular Agents -- therapeutic use
- Polymorphism, Single Nucleotide -- genetics
- Prospective Studies
- TRPV Cation Channels -- genetics
- Topiramate -- therapeutic use
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.